Detalhe da pesquisa
1.
Allogeneic immunity clears latent virus following allogeneic stem cell transplantation in SIV-infected ART-suppressed macaques.
Immunity
; 56(7): 1649-1663.e5, 2023 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37236188
2.
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma.
N Engl J Med
; 386(7): 629-639, 2022 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34904798
3.
Impact of CD19 CAR T-cell product type on outcomes in relapsed or refractory aggressive B-NHL.
Blood
; 139(26): 3722-3731, 2022 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35439295
4.
A phase II trial of netupitant/palonosetron for prevention of chemotherapy-induced nausea/vomiting in patients receiving BEAM prior to hematopoietic cell transplantation.
J Oncol Pharm Pract
; 30(2): 304-312, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37151021
5.
Omidubicel vs standard myeloablative umbilical cord blood transplantation: results of a phase 3 randomized study.
Blood
; 138(16): 1429-1440, 2021 10 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34157093
6.
Day 4 collection of granulocyte colony-stimulating factor-mobilized HLA-matched sibling donor peripheral blood allografts demonstrates no long-term increase in chronic graft-versus-host disease or relapse rates.
Cytotherapy
; 25(4): 423-431, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36690537
7.
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
N Engl J Med
; 380(1): 45-56, 2019 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30501490
8.
Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study.
Lancet Oncol
; 22(10): 1403-1415, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34516954
9.
Graft-versus-host disease after liver transplantation is associated with bone marrow failure, hemophagocytosis, and DNMT3A mutations.
Am J Transplant
; 21(12): 3894-3906, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33961341
10.
Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades.
Haematologica
; 106(6): 1599-1607, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32499241
11.
Prolonged hematologic toxicity following treatment with chimeric antigen receptor T cells in patients with hematologic malignancies.
Am J Hematol
; 96(4): 455-461, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33529419
12.
Terumo spectra optia leukapheresis of cynomolgus macaques for hematopoietic stem cell and T cell collection.
J Clin Apher
; 36(1): 67-77, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32941672
13.
Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic.
Biol Blood Marrow Transplant
; 26(7): 1239-1246, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32298807
14.
Viral opportunistic infections in Mauritian cynomolgus macaques undergoing allogeneic stem cell transplantation mirror human transplant infectious disease complications.
Xenotransplantation
; 27(4): e12578, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31930750
15.
Association of Antiepileptic Medications with Outcomes after Allogeneic Hematopoietic Cell Transplantation with Busulfan/Cyclophosphamide Conditioning.
Biol Blood Marrow Transplant
; 25(7): 1424-1431, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30871976
16.
Feasibility and cost analysis of day 4 granulocyte colony-stimulating factor mobilized peripheral blood progenitor cell collection from HLA-matched sibling donors.
Cytotherapy
; 21(7): 725-737, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31085121
17.
Next-generation sequencing-defined minimal residual disease before stem cell transplantation predicts acute myeloid leukemia relapse.
Am J Hematol
; 94(8): 902-912, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31124175
18.
Payment and Care for Hematopoietic Cell Transplantation Patients: Toward a Specialized Medical Home for Complex Care Patients.
Biol Blood Marrow Transplant
; 24(1): 4-12, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28963077
19.
Plerixafor Plus Granulocyte Colony-Stimulating Factor for Patients with Non-Hodgkin Lymphoma and Multiple Myeloma: Long-Term Follow-Up Report.
Biol Blood Marrow Transplant
; 24(6): 1187-1195, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29410180
20.
Assessment of Impact of HLA Type on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia.
Biol Blood Marrow Transplant
; 24(3): 581-586, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29032274